KRISTEN STEVENS: Open Payments
NPI 1285164152 · JEFFERSON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,989 in 33 payments from 7 companies in 2025. Trend: 2023 $162 · 2024 $904 · 2025 $1,989
Food & beverage: $1,989
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 14 | $911 |
| Gilead Sciences, Inc. | 8 | $251 |
| Novo Nordisk Inc | 2 | $215 |
| Ipsen Biopharmaceuticals, Inc | 4 | $190 |
| Janssen Scientific Affairs, LLC | 2 | $186 |
| Intercept Pharmaceuticals, Inc. | 2 | $122 |
| Mirum Pharmaceuticals, Inc. | 1 | $114 |
Products named: REZDIFFRA, Wegovy, IQIRVO, OCALIVA, Livmarli.
Industry payments across LA — which companies pay providers there.
